Brooks Laboratories [BROOKS] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Brooks Laboratories Ltd.

NSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Brooks Laboratories Ltd. wins in 8 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Brooks Laboratories Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 8.34 31.20 Brooks Laboratories Ltd.
Price-to-Book Ratio 1.56 4.05 Brooks Laboratories Ltd.
Debt-to-Equity Ratio 6.77 32.95 Brooks Laboratories Ltd.
PEG Ratio -0.04 1.33 Innova Captab Ltd.
EV/EBITDA 25.01 20.49 Innova Captab Ltd.
Profit Margin (TTM) 24.32% 8.85% Brooks Laboratories Ltd.
Operating Margin (TTM) 2.05% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 2.05% 12.88% Innova Captab Ltd.
Return on Equity -10.16% 13.37% Innova Captab Ltd.
Return on Assets (TTM) -8.06% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $15.98M $-1.09B Brooks Laboratories Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return -54.45% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 2.03 2.76 Brooks Laboratories Ltd.
Enterprise Value $1.95B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.20 2.90 Brooks Laboratories Ltd.
Gross Profit Margin (TTM) 45.68% 35.19% Brooks Laboratories Ltd.
Revenue per Share (TTM) $30 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $7.35 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.81 -0.33 Innova Captab Ltd.

Brooks Laboratories Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

BROOKS
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Brooks Laboratories Ltd.-3.95%3.55%18.08%4.21%-34.87%-17.04%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Brooks Laboratories Ltd.-54.45%6.49%-35.78%-3.14%87.61%87.61%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Brooks Laboratories Ltd. vs Innova Captab Ltd.

MetricBROOKSINNOVACAP
Market Information
Market Cap i₹1.90B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i124,101578,151
90 Day Avg. Volume i195,493217,693
Last Close₹64.40₹857.00
52 Week Range₹36.30 - ₹164.02₹622.00 - ₹1,020.70
% from 52W High-60.74%-16.04%
All-Time High₹198.86 (Jan 06, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-67.62%-31.98%
Growth Metrics
Quarterly Revenue Growth-0.57%0.42%
Quarterly Earnings Growth-0.57%0.23%
Financial Health
Profit Margin (TTM) i0.24%0.09%
Operating Margin (TTM) i0.02%0.13%
Return on Equity (TTM) i-0.10%0.13%
Debt to Equity (MRQ) i6.7732.95
Cash & Liquidity
Book Value per Share (MRQ)₹39.30₹178.28
Cash per Share (MRQ)₹0.36₹10.22
Operating Cash Flow (TTM) i₹-42,666,000₹282.88M
Levered Free Cash Flow (TTM) i₹-99,670,000₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Brooks Laboratories Ltd. vs Innova Captab Ltd.

MetricBROOKS (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i8.3431.20
Forward P/E i10.5521.90
PEG Ratio i-0.041.33
Price to Sales (TTM) i2.032.76
Price to Book (MRQ) i1.564.05
Market Capitalization
Market Capitalization i₹1.90B₹41.43B
Enterprise Value i₹1.95B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.202.90
Enterprise to EBITDA i25.0120.49
Risk & Other Metrics
Beta i0.81-0.33
Book Value per Share (MRQ) i₹39.30₹178.28

Financial Statements Comparison: Brooks Laboratories Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBROOKS (2025)INNOVACAP (2025)
Revenue/Sales i821.86M12.34B
Cost of Goods Sold i593.60M8.38B
COGS % of Revenue i72.2%67.9%
Gross Profit i228.25M3.96B
Gross Margin i27.8%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i65.27M1.65B
Operating Margin i7.9%13.4%
EBITDA i-42.57M2.00B
EBITDA Margin i-5.2%16.2%
Pre-Tax Income i-97.92M1.71B
Pre-Tax Income % of Revenue i-11.9%13.9%
Income Tax i1.75M427.58M
Income Tax % of Revenue i0.2%3.5%
Net Income (Profit) i-99.67M1.28B
Profit Margin i-12.1%10.4%

Balance Sheet & Liquidity Metrics

MetricBROOKS (2025)INNOVACAP (2025)
Cash & Equivalents i434,000155.19M
Total Current Assets i338.77M7.03B
Total Current Assets % of Revenue i41.2%57.0%
Total Current Liabilities i228.44M3.53B
Total Current Liabilities % of Revenue i27.8%28.6%
Long-Term Debt i13.70M2.45B
Long-Term Debt % of Revenue i1.7%19.8%
Total Shareholders Equity i981.04M9.59B
Retained Earnings i-486.52M4.53B
Retained Earnings % of Revenue i-59.2%36.7%
Property, Plant & Equipment i3.45M442.93M

Cash Flow Statement Comparison

MetricBROOKS (2025)INNOVACAP (2025)
Operating Cash Flow i-42.67M282.88M
Operating Cash Flow % of Revenue i-5.2%2.3%
Capital Expenditures i-9.13M-1.72B
Free Cash Flow i15.98M-1.09B
FCF Margin i1.9%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBROOKSINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i29.46M57.22M
Float Shares i13.27M15.91M
% Held by Insiders i56.02%72.19%
% Held by Institutions i9.90%19.22%
% Held by Public i34.08%8.59%

Dividend Analysis & Yield Comparison: Brooks Laboratories Ltd. vs Innova Captab Ltd.

MetricBROOKSINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026